← All investors

MC

Firm & fund profile / Sourced portfolio

March Capital

Tracked participation in 6 Atlas companies, with 3 explicitly attributed leads.

Firm website ↗

6portfolio companies

12round participations

3lead positions

$125Mled round total

Conviction

Most recent leads

The latest rounds this investor is sourced as leading, newest first.

Apr 2024LuminanceSeries B$40M Nov 2022Parallel DomainSeries B$30M Dec 2021SukiSeries C$55Mat $400M valuation

Capital activity

Portfolio

CompanyLatest valuationFirst → latestRoundsRoleAttributed partner

TATogether AI$8.3BFeb 2025 → Jul 20262 roundsParticipant—

LSLila SciencesScienceLila Sciences (lila.ai) is a privately held AI-for-science company building what it calls an “operating system for…$1.3Bvaluation$985MraisedRecent roundsSeries A (final close / total round close as disclosed) · Oct 2025$350M · led by Braidwell, Collective GlobalSeed · Oct 2025$200M · Abu Dhabi Investment Authority (ADIA) (wholly owned subsidiary), Altitude Life Science Ventures +7Series A (milestone close) · Sep 2025$235M · led by Braidwell, Collective Global +1Lila Sciences$1.3BMar 2025 → Oct 20254 roundsParticipant—

SSuki$400MDec 2021 → Oct 20242 rounds1 led—

LLuminance—Apr 2024 → Apr 20242 rounds1 led—

GGenerate:BiomedicinesScienceGenerate:Biomedicines (Nasdaq: GENB) is a clinical-stage therapeutics company focused on “generative biology”: a…$1.1BraisedRecent roundsIPO (initial public offering) · Feb 2026$400M · Cantor Fitzgerald & Co., Goldman Sachs & Co. LLC +3Series C · Sep 2023$273M · Abu Dhabi Investment Authority (ADIA) wholly-owned subsidiary, Abu Dhabi Investment Authority (wholly-owned subsidiary) +10Series B · Nov 2021$370M · Abu Dhabi Investment Authority (ADIA) wholly-owned subsidiary, Abu Dhabi Investment Authority (wholly-owned subsidiary) +8Generate:Biomedicines—Sep 2023 → Sep 20231 roundParticipant—

PDParallel Domain—Nov 2022 → Nov 20221 round1 ledJulia Klein

DateCompanyRoundRaisedValuationRoleEvidence

Jul 01, 2026TATogether AISeries C$800M$8.3BParticipant

Oct 10, 2025LSLila SciencesScienceLila Sciences (lila.ai) is a privately held AI-for-science company building what it calls an “operating system for…$1.3Bvaluation$985MraisedRecent roundsSeries A (final close / total round close as disclosed) · Oct 2025$350M · led by Braidwell, Collective GlobalSeed · Oct 2025$200M · Abu Dhabi Investment Authority (ADIA) (wholly owned subsidiary), Altitude Life Science Ventures +7Series A (milestone close) · Sep 2025$235M · led by Braidwell, Collective Global +1Lila SciencesSeries A (final close / total round close as disclosed)$350M$1.3BParticipant

Source ↗+1 ↗

Oct 03, 2025LSLila SciencesScienceLila Sciences (lila.ai) is a privately held AI-for-science company building what it calls an “operating system for…$1.3Bvaluation$985MraisedRecent roundsSeries A (final close / total round close as disclosed) · Oct 2025$350M · led by Braidwell, Collective GlobalSeed · Oct 2025$200M · Abu Dhabi Investment Authority (ADIA) (wholly owned subsidiary), Altitude Life Science Ventures +7Series A (milestone close) · Sep 2025$235M · led by Braidwell, Collective Global +1Lila SciencesSeed$200M—Participant

Sep 15, 2025LSLila SciencesScienceLila Sciences (lila.ai) is a privately held AI-for-science company building what it calls an “operating system for…$1.3Bvaluation$985MraisedRecent roundsSeries A (final close / total round close as disclosed) · Oct 2025$350M · led by Braidwell, Collective GlobalSeed · Oct 2025$200M · Abu Dhabi Investment Authority (ADIA) (wholly owned subsidiary), Altitude Life Science Ventures +7Series A (milestone close) · Sep 2025$235M · led by Braidwell, Collective Global +1Lila SciencesSeries A (milestone close)$235M—Participant

Mar 10, 2025LSLila SciencesScienceLila Sciences (lila.ai) is a privately held AI-for-science company building what it calls an “operating system for…$1.3Bvaluation$985MraisedRecent roundsSeries A (final close / total round close as disclosed) · Oct 2025$350M · led by Braidwell, Collective GlobalSeed · Oct 2025$200M · Abu Dhabi Investment Authority (ADIA) (wholly owned subsidiary), Altitude Life Science Ventures +7Series A (milestone close) · Sep 2025$235M · led by Braidwell, Collective Global +1Lila SciencesSeed (committed seed capital)$200M—Participant

Feb 20, 2025TATogether AISeries B$305M$3.3BParticipant

Oct 10, 2024SSukiSeries D$70M—Participant

Apr 24, 2024LLuminanceSeries B$40M—Lead

Sep 14, 2023GGenerate:BiomedicinesScienceGenerate:Biomedicines (Nasdaq: GENB) is a clinical-stage therapeutics company focused on “generative biology”: a…$1.1BraisedRecent roundsIPO (initial public offering) · Feb 2026$400M · Cantor Fitzgerald & Co., Goldman Sachs & Co. LLC +3Series C · Sep 2023$273M · Abu Dhabi Investment Authority (ADIA) wholly-owned subsidiary, Abu Dhabi Investment Authority (wholly-owned subsidiary) +10Series B · Nov 2021$370M · Abu Dhabi Investment Authority (ADIA) wholly-owned subsidiary, Abu Dhabi Investment Authority (wholly-owned subsidiary) +8Generate:BiomedicinesSeries C$273M—Participant

Nov 16, 2022PDParallel DomainSeries B$30M—Lead · Julia Klein

Dec 07, 2021SSukiSeries C$55M$400MLead

UndatedLLuminanceSeries C$75M—Participant

DateCompanyRoundRaisedValuationRoleEvidence

Jul 01, 2026TATogether AISeries C$800M$8.3BParticipant

Oct 10, 2025LSLila SciencesScienceLila Sciences (lila.ai) is a privately held AI-for-science company building what it calls an “operating system for…$1.3Bvaluation$985MraisedRecent roundsSeries A (final close / total round close as disclosed) · Oct 2025$350M · led by Braidwell, Collective GlobalSeed · Oct 2025$200M · Abu Dhabi Investment Authority (ADIA) (wholly owned subsidiary), Altitude Life Science Ventures +7Series A (milestone close) · Sep 2025$235M · led by Braidwell, Collective Global +1Lila SciencesSeries A (final close / total round close as disclosed)$350M$1.3BParticipant

Source ↗+1 ↗

Feb 20, 2025TATogether AISeries B$305M$3.3BParticipant

Sep 14, 2023GGenerate:BiomedicinesScienceGenerate:Biomedicines (Nasdaq: GENB) is a clinical-stage therapeutics company focused on “generative biology”: a…$1.1BraisedRecent roundsIPO (initial public offering) · Feb 2026$400M · Cantor Fitzgerald & Co., Goldman Sachs & Co. LLC +3Series C · Sep 2023$273M · Abu Dhabi Investment Authority (ADIA) wholly-owned subsidiary, Abu Dhabi Investment Authority (wholly-owned subsidiary) +10Series B · Nov 2021$370M · Abu Dhabi Investment Authority (ADIA) wholly-owned subsidiary, Abu Dhabi Investment Authority (wholly-owned subsidiary) +8Generate:BiomedicinesSeries C$273M—Participant

Sep 15, 2025LSLila SciencesScienceLila Sciences (lila.ai) is a privately held AI-for-science company building what it calls an “operating system for…$1.3Bvaluation$985MraisedRecent roundsSeries A (final close / total round close as disclosed) · Oct 2025$350M · led by Braidwell, Collective GlobalSeed · Oct 2025$200M · Abu Dhabi Investment Authority (ADIA) (wholly owned subsidiary), Altitude Life Science Ventures +7Series A (milestone close) · Sep 2025$235M · led by Braidwell, Collective Global +1Lila SciencesSeries A (milestone close)$235M—Participant

Oct 03, 2025LSLila SciencesScienceLila Sciences (lila.ai) is a privately held AI-for-science company building what it calls an “operating system for…$1.3Bvaluation$985MraisedRecent roundsSeries A (final close / total round close as disclosed) · Oct 2025$350M · led by Braidwell, Collective GlobalSeed · Oct 2025$200M · Abu Dhabi Investment Authority (ADIA) (wholly owned subsidiary), Altitude Life Science Ventures +7Series A (milestone close) · Sep 2025$235M · led by Braidwell, Collective Global +1Lila SciencesSeed$200M—Participant

Mar 10, 2025LSLila SciencesScienceLila Sciences (lila.ai) is a privately held AI-for-science company building what it calls an “operating system for…$1.3Bvaluation$985MraisedRecent roundsSeries A (final close / total round close as disclosed) · Oct 2025$350M · led by Braidwell, Collective GlobalSeed · Oct 2025$200M · Abu Dhabi Investment Authority (ADIA) (wholly owned subsidiary), Altitude Life Science Ventures +7Series A (milestone close) · Sep 2025$235M · led by Braidwell, Collective Global +1Lila SciencesSeed (committed seed capital)$200M—Participant

UndatedLLuminanceSeries C$75M—Participant

Oct 10, 2024SSukiSeries D$70M—Participant

Dec 07, 2021SSukiSeries C$55M$400MLead

Apr 24, 2024LLuminanceSeries B$40M—Lead

Nov 16, 2022PDParallel DomainSeries B$30M—Lead · Julia Klein